Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 22;21(6):2194.
doi: 10.3390/ijms21062194.

Role of Interleukin-6 in Depressive Disorder

Emily Yi-Chih Ting  1 , Albert C Yang  2   3 , Shih-Jen Tsai  1   2   4
Affiliations
Review

Role of Interleukin-6 in Depressive Disorder

Emily Yi-Chih Ting et al. Int J Mol Sci. .

Abstract

Major depressive disorder (MDD), which is a leading psychiatric illness across the world, severely affects quality of life and causes an increased incidence of suicide. Evidence from animal as well as clinical studies have indicated that increased peripheral or central cytokine interleukin-6 (IL-6) levels play an important role in stress reaction and depressive disorder, especially physical disorders comorbid with depression. Increased release of IL-6 in MDD has been found to be a factor associated with MDD prognosis and therapeutic response, and may affect a wide range of depressive symptomatology. However, study results of the IL6 genetic effects in MDD are controversial. Increased IL-6 activity may cause depression through activation of hypothalamic-pituitary-adrenal axis or influence of the neurotransmitter metabolism. The important role of neuroinflammation in MDD pathogenesis has created a new perspective that the combining of blood IL-6 and other depression-related cytokine levels may help to classify MDD biological subtypes, which may allow physicians to identify the optimal treatment for MDD patients. To modulate the IL-6 activity by IL-6-related agents, current antidepressive agents, herb medication, pre-/probiotics or non-pharmacological interventions may hold great promise for the MDD patients with inflammatory features.

Keywords: antidepressant; interleukin-6; major depressive disorder; polymorphism; stress.

PubMed Disclaimer

Conflict of interest statement

S.-J.T. has received support from the Taiwan Ministry of Science and Technology, and from the Taipei Veterans General Hospital. There is no commercial or financial involvement that might present an appearance of a conflict of interest in connection with the submitted article. E.Y.-C.T. and A.C.Y declare no conflict of interest.

Figures

Figure 1
Figure 1
Possible role of interleukin-6 (IL-6) in major depression pathogenesis.
See this image and copyright information in PMC

References

    1. Miller A.H. Norman cousins lecture. Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface. Brain. Behav. Immun. 2009;23:149–158. doi: 10.1016/j.bbi.2008.08.006. - DOI - PMC - PubMed
    1. Muller N., Ackenheil M. Psychoneuroimmunology and the cytokine action in the cns: Implications for psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1998;22:1–33. doi: 10.1016/S0278-5846(97)00179-6. - DOI - PubMed
    1. Dunn A.J., Wang J., Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 1999;461:117–127. - PubMed
    1. Dantzer R., Wollman E., Vitkovic L., Yirmiya R. Cytokines and depression: Fortuitous or causative association? Mol. Psychiatry. 1999;4:328–332. doi: 10.1038/sj.mp.4000572. - DOI - PubMed
    1. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry. 1999;4:317–327. doi: 10.1038/sj.mp.4000586. - DOI - PubMed

MeSH terms

LinkOut - more resources